Clinical Trial Update: An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels [Phase 2]

View source ↗

Summary

An open-label Phase 2 clinical trial evaluating Vascazen in cardiac rehab patients with deficient blood omega-3 fatty acid levels is being updated; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Vascazen

Snippet

Sponsor: New York Hospital Queens | Conditions: Dyslipidemia | Phase 2 | Status: UNKNOWN